by Jordana Choucair | Jan 12, 2023 | Life Sciences
The U.S. Department of Health and Human Services (HHS) announced the specific timeline for the first year of Medicare prescription drug price negotiations. HHS will reveal in early September the first 10 high-cost drugs, and plans to negotiate the prices with drug...
by Jordana Choucair | Jan 12, 2023 | Life Sciences
Mark Cuban Cost Plus Drugs announced it will partner with pharmacy benefits manager RxPreferred Benefits to an effort to offer lower priced drugs through some employer-backed health insurance plans. Under the partnership, RxPreferred Benefits’ customers will have the...
by Jordana Choucair | Jan 12, 2023 | Opioid/Substance Use Disorders
New Jersey Attorney General Matthew Platkin announced the state will join a national settlement with several pharmacy chains and drug makers for their roles in the opioid epidemic. The state has signed five agreements with CVS, Walgreens, Walmart, Teva...
by Jordana Choucair | Jan 12, 2023 | Public Health/Prevention
The Biden administration renewed the COVID-19 public health emergency (PHE) for another 90 days. The renewal comes amid the emergence of the Omicron XBB.1.5 subvariant and a spike in new cases. HHS Secretary Xavier Becerra has pledged HHS would give states and health...
by Jordana Choucair | Jan 12, 2023 | Transition to Value
A study published in American Journal of Managed Care found that a risk stratification model developed by Medical Home Network (MHN) can more accurately identify high- and rising-risk members than traditional models. According to the study, MHN’s AI-based model, which...
Recent Comments